Los Angeles Capital Management
ETON icon

Los Angeles Capital Management’s Eton Pharmaceutcials ETON Stock Holding History

Los Angeles Capital Management’s Portfolio ETON Stock Details ETON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$567K Buy
15,675
+5,406
+53% +$159K ﹤0.01% 880
2026
Q1 		$253K Sell
10,269
-4,362
-30% -$76.3K ﹤0.01% 1078
2025
Q4 		$267K Buy
+14,631
New +$257K ﹤0.01% 1134

Other funds holding ETON

OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Nantahala Capital Management
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Oberweis Asset Management
Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return
National Philanthropic Trust
National Philanthropic Trust Jenkintown, Pennsylvania $6.92B AUM 24.7% 1-Year Est. Return

Los Angeles Capital Management's ETON Position: Q2 2026 in Review

Los Angeles Capital Management increased its Eton Pharmaceutcials (ETON) stake by 53% in Q2 2026, buying an estimated $159K and bringing the position to 15,675 shares worth $567K. The position accounts for ﹤0.01% of the portfolio, ranked #880.

Los Angeles Capital Management first reported a position in ETON in Q4 2025 and has held it in 3 quarters since. 164 funds tracked by Wall St. Rank hold ETON as of Q2 2026.

  • Los Angeles Capital Management held 15,675 shares of Eton Pharmaceutcials worth $567K as of Q2 2026.
  • Los Angeles Capital Management bought 5,406 Eton Pharmaceutcials shares in Q2 2026, an estimated $159K.
  • Eton Pharmaceutcials made up ﹤0.01% of Los Angeles Capital Management's portfolio in Q2 2026, its #880 holding.
  • Los Angeles Capital Management first reported a position in Eton Pharmaceutcials in Q4 2025 and has held it in 3 quarters since.
  • 164 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q2 2026.

Based on Los Angeles Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.